INTERNATIONAL PATENT: CONGRUENCE THERAPEUTICS INC. FILES APPLICATION FOR "MODULATORS OF ALPHA-1 ANTITRYPSIN"

GENEVA, Nov. 23 -- CONGRUENCE THERAPEUTICS INC. (6666 Rue Saint-UrbainSuite 450Montreal, Quebec H2S 3H1) filed a patent application (PCT/CA2025/050702) for "MODULATORS OF ALPHA-1 ANTITRYPSIN" on May 14, 2025. With publication no. WO/2025/236095, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FADER, Lee (486-53 Wharf StreetL'Orignal, Ontario K0B 1K0), KABRO, Anzhelika (815, 49e avenueLachine, Quebec H8T 2T3), RAMTOHUL, Yeeman K. (12665 Boul Gouin OuestPierrefonds, Quebec H8Z 1W6), MICHEL, Nicholas Willet Mitchell (1310 Re...